Aug 11, 6:15 PMSanara MedTech reports Q2 2026 results with non-GAAP EPS -$0.05 (+78% YoY), revenue $28.1M (+9% YoY), misses EPS and revenue estimates
Index
RUT
Market Cap
314.62M
Enterprise Value
347.72M
Income
-32.01M
Sales
109.81M
Book/sh
0.86
Cash/sh
1.68
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
108
IPO
Apr 07, 1994
P/E
-
Forward P/E
58.53
PEG
-
P/S
2.87
P/B
39.63
P/C
20.40
P/FCF
69.92
EV/EBITDA
25.05
EV/Sales
3.17
Quick Ratio
2.30
Current Ratio
2.58
Debt/Eq
6.11
LT Debt/Eq
6.06
Option/Short
No / Yes
EPS (ttm)
-3.71
EPS next Y
0.58
EPS next Q
0.06
EPS this Y
466.67%
EPS next Y
219.09%
EPS next 5Y
-
EPS past 3/5Y
-63.11% -41.80%
Sales past 3/5Y
31.03% 45.92%
EPS Y/Y TTM
-219.19%
Sales Y/Y TTM
12.93%
EPS Q/Q
77.64%
Sales Q/Q
8.93%
Insider Own
47.06%
Insider Trans
0.00%
Inst Own
15.70%
Inst Trans
-25.62%
ROA
-0.34%
ROE
-1.31%
ROIC
-57.08%
Gross Margin
90.77%
Oper. Margin
10.38%
Profit Margin
-29.15%
SMA20
12.22%
SMA50
31.24%
SMA200
51.43%
Trades
Shs Outstand
9.19M
Shs Float
4.87M
52W High
35.95 -4.75%
52W Low
16.05 113.39%
Volatility
0.87% 3.31%
ATR (14)
0.95
RSI (14)
82.34
Beta
1.15
Rel Volume
2.15
Avg Volume
157.15K
Volume
194,065
Perf Week
0.45%
Perf Month
39.62%
Perf Quarter
62.28%
Perf Half Y
75.42%
Perf YTD
46.65%
Perf Year
7.27%
Perf 3Y
-25.54%
Perf 5Y
-4.88%
Perf 10Y
500.74%
Prev Close
34.33
Price
34.24
Change %
-0.26%
Date Action Analyst Rating Change Price Target Change
Jul-30-26Downgrade H.C. Wainwright Buy → Neutral $35
Apr-15-26Initiated Lake Street Buy $32
Mar-26-25Reiterated H.C. Wainwright Buy $50 → $51
Dec-23-24Initiated H.C. Wainwright Buy $50
May-20-22Resumed Cantor Fitzgerald Overweight $45 → $40
Jun-30-21Initiated Cantor Fitzgerald Overweight $45
Aug-11-26 04:10PM
Aug-06-26 03:48PM
Aug-03-26 07:38PM
Jul-30-26 08:30AM
01:03AM
08:30AM Loading…
May-13-26 08:30AM
May-12-26 03:02PM
May-11-26 04:50PM
09:22AM
Apr-14-26 07:30AM
Mar-25-26 08:30AM
Mar-24-26 03:01PM
07:00AM
Mar-23-26 09:20AM
Mar-11-26 07:30AM
06:05PM Loading…
Mar-03-26 06:05PM
07:30AM
Feb-17-26 07:30AM
Jan-23-26 07:30AM
Jan-07-26 04:05PM
Jan-06-26 12:00PM
11:39AM
Dec-10-25 08:37AM
Nov-19-25 07:30AM
Nov-12-25 02:02PM
09:35AM
07:00AM
Nov-11-25 04:05PM
07:30AM
Nov-05-25 09:25AM
05:55PM Loading…
Oct-29-25 05:55PM
Oct-01-25 07:30AM
Sep-02-25 04:30PM
Aug-27-25 04:05PM
Aug-13-25 08:25AM
07:00AM
Aug-12-25 09:33AM
Aug-07-25 10:05AM
Jul-15-25 04:05PM
Jul-14-25 04:05PM
May-15-25 03:06AM
May-14-25 08:50AM
07:00AM
May-13-25 09:39AM
May-08-25 05:15PM
Apr-23-25 08:00AM
Apr-10-25 04:00PM
11:36AM
Mar-26-25 03:01AM
Mar-25-25 09:15AM
07:00AM
Mar-24-25 09:04AM
Mar-11-25 04:05PM
Jan-24-25 07:00AM
Jan-21-25 04:10PM
04:08PM
04:05PM
Nov-25-24 04:05PM
Nov-14-24 02:10AM
Nov-12-24 04:15PM
Nov-11-24 07:17AM
Oct-31-24 09:15AM
Oct-07-24 09:15AM
Sep-11-24 06:30AM
Aug-12-24 04:15PM
Jul-30-24 09:15AM
May-15-24 03:05AM
May-13-24 10:54PM
10:52AM
09:15AM
Apr-29-24 09:15AM
Apr-18-24 09:15AM
Apr-05-24 09:00AM
Mar-29-24 09:41AM
Mar-25-24 08:53PM
05:52PM
04:05PM
Mar-13-24 09:15AM
Feb-22-24 09:15AM
Jan-03-24 09:15AM
Nov-30-23 09:15AM
Nov-15-23 01:44PM
Nov-13-23 05:29PM
04:05PM
Oct-30-23 09:15AM
Oct-10-23 09:15AM
Sep-12-23 09:15AM
Aug-14-23 04:05PM
Aug-02-23 09:15AM
Aug-01-23 04:05PM
May-15-23 04:15PM
May-03-23 09:15AM
Apr-04-23 09:15AM
Mar-20-23 04:15PM
Mar-06-23 09:15AM
Feb-22-23 09:15AM
Nov-21-22 09:15AM
Nov-14-22 04:15PM
Nov-03-22 09:15AM
06:30AM
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Executive ChairmanMr. Ronald T. Nixon
PresidentMr. Seth D. Yon
Chief Financial OfficerMs. Elizabeth B. Taylor
Chief Operating OfficerMr. Jacob A. Waldrop
President & CEO of THPMr. Suresh V. Muppalla